Beyond weight loss, many patients experience other metabolic improvements, such as better blood pressure, improved cholesterol levels, and a reduced risk of developing type 2 diabetes
SoDWhelanKRossiMMorrisonMHoltmannGKellyJTet al
Current UK professional guidance emphasises: Patients should inform their surgical team and anaesthetist that they are taking a GLP-1 medication as soon as surgery is planned Healthcare professionals should specifically ask about GLP-1 use during preoperative assessment, as patients may not recognise these medications as relevant to their surgery The decision to continue or pause GLP-1 therapy should be made on an individual risk-based assessment , considering the type of surgery, the specific GLP-1 agent, dose escalation status, presence of gastrointestinal symptoms, and the patient's clinical circumstances Many patients can safely continue GLP-1 medications perioperatively with appropriate precautions, while those at higher risk may benefit from temporary cessation The Summary of Product Characteristics (SmPC) for GLP-1 medications notes the delayed gastric emptying effect, which anaesthetists consider when planning perioperative care

And that helps people feel fuller for longer, and so they won't reach out to food as often, which results in weight loss
The Litigation Landscape: Has expanded rapidly as medical research continues to establish correlations between GLP-1 drug use and sudden vision impairment